TP53 and COVID-19: TP53 has in several other studies previously been identified as a hub gene, in whole blood from COVID-19 patients [51], and has been shown to interact with ACE2 in SARS-CoV-2-infected human induced pluripotent stem cell-derived cardiomyocytes[52].